• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

先进技术在改善糖尿病治疗效果中的作用。

The role of advanced technologies in improving diabetes outcomes.

作者信息

Marrero David G, Parkin Christopher G, Aleppo Grazia, Hirsch Irl B, McGill Janet, Galindo Rodolfo J, Kruger Davida F, Levy Carol J, Carlson Anders L, Umpierrez Guillermo E

机构信息

CGParkin Communications, Inc, 2675 Windmill Pkwy, Ste 2721, Henderson, NV 89074. Email:

出版信息

Am J Manag Care. 2025 Apr 1;31(4):e102-e112. doi: 10.37765/ajmc.2025.89725.

DOI:10.37765/ajmc.2025.89725
PMID:40227450
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12232999/
Abstract

OBJECTIVES

To discuss the current state of diabetes care in America, the value and utility of innovative diabetes technologies, barriers to access to quality diabetes care and technologies, and how a value-based model of diabetes care can improve outcomes and reduce costs.

STUDY DESIGN

Narrative review of the current state of diabetes care in America and use of diabetes technologies such as continuous glucose monitoring (CGM) and automated insulin delivery (AID) systems.

METHODS

An internet search of relevant studies and government reports was conducted.

RESULTS

Numerous studies have shown that use of CGM and AID improves glycemia, diabetes-related events, and health care resource utilization and lowers overall health care costs. Despite these demonstrated benefits, the majority of individuals with diabetes are not achieving their glycemic goals. Although many of these individuals have limited access to these technologies due to restrictive coverage eligibility criteria, significant disparities exist in technology use within racial/ethnic minority populations and communities of lower socioeconomic status. Transitioning to a value-based approach to diabetes care supports the Quintuple Aim framework.

CONCLUSIONS

Shifting our current health care delivery paradigm from the traditional volume-based, fee-for-service model to a value-based model that takes a proactive approach could improve patient outcomes and overall quality of life while helping to reduce the long-term costs of diabetes care.

摘要

目的

探讨美国糖尿病护理的现状、创新糖尿病技术的价值和效用、获得优质糖尿病护理及技术的障碍,以及基于价值的糖尿病护理模式如何改善治疗效果并降低成本。

研究设计

对美国糖尿病护理现状以及连续血糖监测(CGM)和自动胰岛素输送(AID)系统等糖尿病技术的使用情况进行叙述性综述。

方法

对相关研究和政府报告进行互联网搜索。

结果

大量研究表明,使用CGM和AID可改善血糖水平、减少糖尿病相关事件、提高医疗资源利用率并降低总体医疗成本。尽管有这些已证实的益处,但大多数糖尿病患者并未实现其血糖目标。由于覆盖资格标准严格,许多患者难以获得这些技术,而且在种族/族裔少数群体和社会经济地位较低的社区中,技术使用存在显著差异。向基于价值的糖尿病护理方法转变有助于实现“五重目标”框架。

结论

将我们当前的医疗服务模式从传统的基于数量的收费服务模式转变为采取积极主动方法的基于价值的模式,可改善患者治疗效果和总体生活质量,同时有助于降低糖尿病护理的长期成本。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/28b8/12232999/ef67f469aeb7/nihms-2087526-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/28b8/12232999/ef67f469aeb7/nihms-2087526-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/28b8/12232999/ef67f469aeb7/nihms-2087526-f0001.jpg

相似文献

1
The role of advanced technologies in improving diabetes outcomes.先进技术在改善糖尿病治疗效果中的作用。
Am J Manag Care. 2025 Apr 1;31(4):e102-e112. doi: 10.37765/ajmc.2025.89725.
2
Methods for insulin delivery and glucose monitoring in diabetes: summary of a comparative effectiveness review.糖尿病胰岛素给药与血糖监测方法:一项比较有效性综述的总结
J Manag Care Pharm. 2012 Aug;18(6 Suppl):S1-17. doi: 10.18553/jmcp.2012.18.s6-A.1.
3
Integrated sensor-augmented pump therapy systems [the MiniMed® Paradigm™ Veo system and the Vibe™ and G4® PLATINUM CGM (continuous glucose monitoring) system] for managing blood glucose levels in type 1 diabetes: a systematic review and economic evaluation.用于管理1型糖尿病患者血糖水平的集成式传感器增强泵治疗系统[美敦力MiniMed® Paradigm™ Veo系统以及Vibe™和G4® PLATINUM连续血糖监测(CGM)系统]:一项系统综述与经济学评估
Health Technol Assess. 2016 Feb;20(17):v-xxxi, 1-251. doi: 10.3310/hta20170.
4
The health economics of insulin therapy: How do we address the rising demands, costs, inequalities and barriers to achieving optimal outcomes.胰岛素治疗的卫生经济学:我们如何应对不断增长的需求、成本、不平等现象以及实现最佳治疗效果的障碍。
Diabetes Obes Metab. 2025 Jul;27 Suppl 5(Suppl 5):24-35. doi: 10.1111/dom.16488. Epub 2025 Jun 4.
5
Continuous glucose monitoring systems for type 1 diabetes mellitus.1型糖尿病的连续血糖监测系统
Cochrane Database Syst Rev. 2012 Jan 18;1(1):CD008101. doi: 10.1002/14651858.CD008101.pub2.
6
Considerations With Using a CGM in Older Individuals.老年个体使用连续血糖监测仪的注意事项。
Sr Care Pharm. 2025 Jul 1;40(7):283-287. doi: 10.4140/TCP.n.2025.283.
7
Management of urinary stones by experts in stone disease (ESD 2025).结石病专家对尿路结石的管理(2025年结石病专家共识)
Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085.
8
Continuous subcutaneous insulin infusion versus multiple daily injections of insulin for pregnant women with diabetes.糖尿病孕妇持续皮下胰岛素输注与多次皮下注射胰岛素的比较
Cochrane Database Syst Rev. 2016 Jun 7;2016(6):CD005542. doi: 10.1002/14651858.CD005542.pub3.
9
Oral anti-diabetic agents for women with established diabetes/impaired glucose tolerance or previous gestational diabetes planning pregnancy, or pregnant women with pre-existing diabetes.用于患有已确诊糖尿病/糖耐量受损或既往妊娠糖尿病且计划怀孕的女性,或患有孕前糖尿病的孕妇的口服抗糖尿病药物。
Cochrane Database Syst Rev. 2017 Oct 18;10(10):CD007724. doi: 10.1002/14651858.CD007724.pub3.
10
Real world evidence of insulin and biosimilar insulin therapy-Opportunities to improve adherence, outcomes and cost-effectiveness.胰岛素及生物类似物胰岛素治疗的真实世界证据——改善依从性、治疗效果和成本效益的机遇
Diabetes Obes Metab. 2025 Apr 15. doi: 10.1111/dom.16386.

引用本文的文献

1
A retrospective analysis of the prognostic implications of glycemic variability on all-cause mortality in critically ill patients with mitral valve disease.对二尖瓣疾病危重症患者血糖变异性对全因死亡率的预后影响的回顾性分析。
Front Endocrinol (Lausanne). 2025 Jul 14;16:1620762. doi: 10.3389/fendo.2025.1620762. eCollection 2025.

本文引用的文献

1
Reduction in Diabetes-Related Hospitalizations and Medical Costs After Dexcom G6 Continuous Glucose Monitor Initiation in People with Type 2 Diabetes Using Intensive Insulin Therapy.使用强化胰岛素治疗的 2 型糖尿病患者启用 Dexcom G6 连续血糖监测后,糖尿病相关住院和医疗费用减少。
Adv Ther. 2024 Jun;41(6):2299-2306. doi: 10.1007/s12325-024-02851-8. Epub 2024 Apr 15.
2
The Potential Impact of Continuous Glucose Monitoring Use on Diabetes-Related Attitudes and Behaviors in Adults with Type 2 Diabetes: A Qualitative Investigation of the Patient Experience.连续血糖监测在成人 2 型糖尿病患者中的使用对糖尿病相关态度和行为的潜在影响:患者体验的定性研究。
Diabetes Technol Ther. 2024 Oct;26(10):700-708. doi: 10.1089/dia.2023.0612. Epub 2024 May 13.
3
Increasing Continuous Glucose Monitoring Use for Non-Hispanic Black and Hispanic People With Type 1 Diabetes: Results From the T1D Exchange Quality Improvement Collaborative Equity Study.增加非西班牙裔黑人和西班牙裔1型糖尿病患者连续血糖监测的使用:T1D交换质量改进协作公平性研究结果
Clin Diabetes. 2024 Winter;42(1):40-48. doi: 10.2337/cd23-0050. Epub 2023 Oct 13.
4
7. Diabetes Technology: Standards of Care in Diabetes-2024.7. 糖尿病技术:2024年糖尿病护理标准
Diabetes Care. 2024 Jan 1;47(Suppl 1):S126-S144. doi: 10.2337/dc24-S007.
5
A Multicenter Prospective Evaluation of the Benefits of Two Advanced Hybrid Closed-Loop Systems in Glucose Control and Patient-Reported Outcomes in a Real-world Setting.多中心前瞻性评价两种先进的混合闭环系统在真实环境下血糖控制和患者报告结局方面的获益。
Diabetes Care. 2024 Feb 1;47(2):216-224. doi: 10.2337/dc23-1355.
6
Economic Costs of Diabetes in the U.S. in 2022.2022 年美国糖尿病的经济成本。
Diabetes Care. 2024 Jan 1;47(1):26-43. doi: 10.2337/dci23-0085.
7
Longitudinal Trends in Glycemic Outcomes and Technology Use for Over 48,000 People with Type 1 Diabetes (2016-2022) from the T1D Exchange Quality Improvement Collaborative.48000 余位 1 型糖尿病患者(2016-2022 年)的血糖控制结果和技术使用的纵向趋势:来自 T1D Exchange 质量改进合作研究。
Diabetes Technol Ther. 2023 Nov;25(11):765-773. doi: 10.1089/dia.2023.0320. Epub 2023 Oct 16.
8
Satisfaction with continuous glucose monitoring is positively correlated with time in range in children with type 1 diabetes.儿童 1 型糖尿病患者的血糖达标时间与连续血糖监测的满意度呈正相关。
Diabetes Res Clin Pract. 2023 Oct;204:110895. doi: 10.1016/j.diabres.2023.110895. Epub 2023 Sep 6.
9
Is Continuous Glucose Monitoring a Tool, an Intervention, or Both?连续血糖监测:仅仅是工具,还是干预手段,抑或兼而有之?
Diabetes Technol Ther. 2023 Jun;25(S3):S48-S55. doi: 10.1089/dia.2023.0025.
10
Impact of continuous glucose monitoring on glycemic control and its derived metrics in type 1 diabetes: a longitudinal study.连续血糖监测对 1 型糖尿病患者血糖控制及其衍生指标的影响:一项纵向研究。
Front Endocrinol (Lausanne). 2023 May 15;14:1165471. doi: 10.3389/fendo.2023.1165471. eCollection 2023.